Effectiveness and safety of absorbable mesh suture for treatment of lower face laxity

Edencolors (Thailand) Co., Ltd.0 个研究点目标入组 40 人开始时间: 2021年5月20日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•1. Thai healthy volunteers aged 30-55 years
•2. Body mass index < 30 kg/m2
•3. Patients with mild to moderate facial laxity
•4. No underlying disease, not taking anti-inflammatory drug, antiplatelet drug, vitamin C, or vitamin E

•1. Patients who are pregnant, lactating, and postpartum within 3 months
•2. Patients with history of polydioxanone, xylocaine, and adrenaline allergy
•3. Patients with other skin diseases, or having infection at the area of face
•4. Immunocompromised patients
•5. Patients with hypertrophic scar or keloid
•6. Patients with history of regular smoking
•7. Patients treated with botulinum toxin or laser on the face in the past 6 months
•8. Patients treated with filler or mesh suture on the face in the past 12 months

发起方

Edencolors (Thailand) Co., Ltd.